Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer

Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer

There was no impact of sTgAb on the initial clinical presentation and the response to therapy in low-risk patients treated with or without RA. sTgAb trend is more useful than an absolute value to predict a SIR.

Read the article by clicking here.